[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336275-105":59,"doc-detail-336275-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","toward-personalized-skin-cancer-care-multiple-skin-cancer-development-in-five-cohorts-overview","Toward personalized skin cancer care - multiple skin cancer development in five cohorts - overview","","Toward personalized skin cancer care examines patterns of multiple skin cancer development across five cohorts, focusing on how soon additional skin cancers appear after an initial diagnosis. The study quantifies the proportion of patients receiving treatment for more than one skin cancer and characterizes timing, showing that a substantial share develop subsequent cancers within two years. Results also highlight a small group with 10 or more skin cancers that contributes a disproportionate portion of total treatments, informing risk-aware care planning.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/toward-personalized-skin-cancer-care-multiple-skin-cancer-development-in-five-cohorts-overview/336275/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/toward-personalized-skin-cancer-care-multiple-skin-cancer-development-in-five-cohorts-overview/336275.png","ImageObject",300,407,{"name":92,"@type":93},"Eliana","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":8},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How many patients are treated for more than one skin cancer in the cohorts?","Question",{"text":112,"@type":113},"Forty-three percent of patients were treated for more than one skin cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How soon after the first skin cancer do most subsequent cancers occur?",{"text":117,"@type":113},"The majority of subsequent skin cancers occurred within two years after the initial skin cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the significance of patients treated for 10 or more skin cancers?",{"text":121,"@type":113},"Only 3% of patients were treated for 10 or more skin cancers, but they accounted for 22% of all skin cancer treatments in the cohort.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336275,1790014359,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":8,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":129,"read_time":144,"preview_page_count":19,"preview_urls":145},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","medRxiv preprint doi: [https://doi.org/10.1101/2024.05.06.24306947](https://doi.org/10.1101/2024.05.06.24306947); this version posted May 7, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available  \nfor use under a CC0 license.  \nToward personalized skin cancer care: multiple skin cancer development in five cohorts  \nLee Wheless, MD, PhD1,2,3, Kai-Ping Liao, PhD4, Siwei Zheng, MS5, Yao Li, MS4, Lydia Yao, MS5, Yaomin Xu, PhD5, Christopher Madden, MD6, Jacqueline Ike, MHS7, Isabelle T Smith, BS8, Dominique Mosley, MD9, Sarah Grossarth, MPH10, Rebecca I Hartman, MD, MPH11,12, Otis Wilson1, MS, Adriana Hung, MD, MPH1,13, Mackenzie R Wehner, MD, MPhil4,14  \n1 Tennessee Valley Healthcare System VA Medical Center, 2Vanderbilt University Medical Center Department of Medicine, Division of Epidemiology Vanderbilt University Medical Center; 3 Department of Dermatology, Nashville, Tennessee; 4 University of Texas MD Anderson Cancer Center, Department of Health Services Research, 5 Department of Biostatistics, Vanderbilt University Medical Center , Nashville, Tennessee; 6State University of New York Downstate College of Medicine, Brooklyn, New York; 7 Meharry Medical College, Nashville, Tennessee; 8Vanderbilt University, Nashville, Tennessee; 9Vanderbilt University School of Medicine, Nashville, Tennessee; 10Quillen College of Medicine, East Tennessee State University, Johnson City, TN; 11VA Boston Healthcare System, 12 Brigham and Women’s Hospital Department of Dermatology, 13 Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, 14 University of Texas MD Anderson Cancer Center, Department of Dermatology  \nCorresponding author email: [lee.e.wheless@vumc.org](lee.e.wheless@vumc.org)  \n719 Thompson Lane, Suite 26300  \nNashville, TN 37215  \nWord count: 2573  \nAbstract: 225  \nTables: 3  \nNOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice.  \nmedRxiv preprint doi: [https://doi.org/10.1101/2024.05.06.24306947](https://doi.org/10.1101/2024.05.06.24306947); this version posted May 7, 2024. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available  \nfor use under a CC0 license.  \nFigures: 2  \nKey words: skin cancer, epidemiology, cohort study  \nConflict of interest: The authors have no conflicts to declare  \nStudy approved as VUMC IRB \\#200335 exempt non-human subjects research, VA IRB 1657284 exempt research, and MDA IRB 2019-0966 approved.  \nAbbreviations:  \nCPT-current procedural terminology  \nEHR-electronic health record  \nICD-international classification of disease  \nIRB – Institutional Review Board  \nVINCI – Veteran’s Administration Informatics and Computing Infrastructure  \nVUMC-Vanderbilt University Medical Center  \nFunding and Acknowledgements  \nDr. Wheless is supported by VA CSR&D grant IK2 CX002452. Dr. Hartman is supported by VA CSR&D grant IK2 CX002531. Dr. Wehner is supported by NCI grant K08CA263298. This research was supported by  \nCancer Prevention and Research Institute of Texas RR190078 (MRW) and a grant from the University of  \nTexas Rising STARs program (MRW), as well as, in part, by Cancer Center Support Grant P30 CA016672 to MD Anderson Cancer Center. MRW is a Cancer Prevention and Research Institute of Texas Scholar in  \nCancer Research. The funder had no role in the design and conduct of the study; collection, management,  \nanalysis, and interpretation of the data; preparation, review, or approval of the manuscri","cbCaicdipDY5Plj3","https://ap.wps.com/l/cbCaicdipDY5Plj3","pdf",217510,22,"English","# Key points\n## Question\n## Findings\n## Meaning","[{\"question\":\"How many patients are treated for more than one skin cancer in the cohorts?\",\"answer\":\"Forty-three percent of patients were treated for more than one skin cancer.\"},{\"question\":\"How soon after the first skin cancer do most subsequent cancers occur?\",\"answer\":\"The majority of subsequent skin cancers occurred within two years after the initial skin cancer.\"},{\"question\":\"What is the significance of patients treated for 10 or more skin cancers?\",\"answer\":\"Only 3% of patients were treated for 10 or more skin cancers, but they accounted for 22% of all skin cancer treatments in the cohort.\"}]","Toward personalized skin cancer care - multiple skin cancer development in five cohorts - overview | PDF",55,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff3328bd584e9d26f0496597071f7224.webp",983,1272,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c614b2094ad1a4b840a7f4953544e269.webp",982,1270,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dbbab953becb853a22e48fe52f3c9374.webp",981,1269,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2feff3ca8abede347725bb4e427474f.webp",980,1268]